tradingkey.logo

Skye Bioscience Inc <SKYE.OQ> expected to post a loss of 29 cents a share - Earnings Preview

ReutersMay 6, 2025 9:07 PM
  • Skye Bioscience Inc SKYE.OQ SKYE.O is expected to show no change in quarterly revenue when it reports results on May 8 (estimated) for the period ending March 31 2025

  • ​LSEG's mean analyst estimate for Skye Bioscience Inc is for a loss of 29 cents per share.

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

  • The mean earnings estimate of analysts was unchanged in the last three months. ​

  • Wall Street's median 12-month price target for Skye Bioscience Inc is $17.50​, above​ its last closing price of $1.99. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING

STARMINESMARTESTIMATE®

LSEG IBES ESTIMATE

ACTUAL

BEAT, MET, MISSED

SURPRISE %

Dec. 31 2024

-0.27

-0.28

-0.24

Beat

15.5

Sep. 30 2024

-0.25

-0.25

-0.10

Beat

60.1

Jun. 30 2024

-0.21

-0.19

-0.20

Missed

-2.6​

Mar. 31 2024

-0.16

-0.16

-0.18

Missed

-12.5

​​Dec. 31 2023

-0.38

-0.38

-0.63

Missed

-65.8

This summary was machine generated May 6 at 21:07 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI